On July 23-24, 2026 , the FDA's Pharmacy Compounding Advisory Committee (PCAC) will convene at the FDA White Oak Campus (10903 New Hampshire Avenue, Silver Spring, MD 20993) to evaluate whether several peptides should be added to the Section 503A bulk drug substances list
Theyve been hailed as game-changers for weight management, diabetes, and even heart and liver health
Developed by Novo Nordisk, Ozempic aids in glycemic control and offers the dual benefit of potential weight loss for individuals managing this chronic condition
Clin Gastroenterol Hepatol 2021
GLP1 support tea designed for metabolism, appetite, and digestive balance
For individuals prescribed Ozempic elsewhere for weight loss, switching to FDA-approved weight management solutions can enhance insurance support and align with best practices